2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction

Medicine & Life Sciences

• Cardiology 100%
• Treatment Failure 97%
• Guidelines 64%
• Comorbidity 14%
• 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 14%
• empagliflozin 14%
• Sodium-Glucose Transport Proteins 13%
• Natriuretic Peptides 11%
• Ventricular Pressure 9%
• Diuretics 9%
• Exercise Test 8%
• Chronic Renal Insufficiency 8%
• Stroke Volume 8%
• Signs and Symptoms 7%
• Weight Loss 7%
• Obesity 6%
• Pharmacology 6%
• Exercise 5%
• Therapeutics 1%